Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Fcgammariib Expression As a Prognostic Marker in Chronic Lymphocytic Leukemia

Rosa Bosch, Gerardo Ferrer, Eva Puy Vicente, Alba Mora, Rajendra N. Damle, Sergey Gorlatov, Kanti Rai, Emili Montserrat, Jorge Sierra, Nicholas Chiorazzi, Carol Moreno

Blood (2015) 126 (23): 1727.

https://doi.org/10.1182/blood.V126.23.1727.1727

Published: 2015

Journal Articles

Ibrutinib Inhibits Concomitant TLR and BCR- Driven Proliferation of Chronic Lymphocytic Leukemia Cells and Overrides the Supportive Survival-Promoting Effects of Microenvironmental Signals

Sonal Temburni, MS, Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Betty Y. Chang, Nicholas Chiorazzi, MD, Rajendra N Damle, PhD

Blood (2014) 124 (21): 3310.

https://doi.org/10.1182/blood.V124.21.3310.3310

Published: 2014

Journal Articles

Reciprocal Densities of CXCR4 and CD5 Define Subfractions of Chronic Lymphocytic Leukemia Clones Differing in Phenotype and Response to Environmental Stimuli: Towards a Better Definition of Targetable Components of Leukemic Clones

Rajendra N Damle, PhD, Sonal Temburni, MS, Cristina Sison, PhD, Jaison Jain, Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2014) 124 (21): 3322.

https://doi.org/10.1182/blood.V124.21.3322.3322

Published: 2014

Journal Articles

Concomitant, T-Independent TLR9-Mediated and BCR-Mediated Activation Provides Signals For Optimal Telomerase Induction In Chronic Lymphocytic Leukemia Cells Regardless Of IGHV Mutation Status

Rajendra N Damle, PhD, Sonal Temburni, MS, Ryon M. Andersen, B.A., Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 4142.

https://doi.org/10.1182/blood.V122.21.4142.4142

Published: 2013

Journal Articles

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

Piers E. M. Patten, Charles C. Chu, Emilia Albesiano, Rajendra N. Damle, Xiao-Jie Yan, Dorothy Kim, Lu Zhang, Amanda R. Magli, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti R. Rai, Sergio Roa, Patricia K. Mongini, Thomas MacCarthy, Matthew D. Scharff, Nicholas Chiorazzi

Blood (2012) 120 (24): 4802–4811.

https://doi.org/10.1182/blood-2012-08-449744

Published: 2012

Includes: Supplemental data

Journal Articles

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Xiao J. Yan, MD, PhD, Wentian Li, Ph.D., Sophia Yancopoulos, PhD, Igor Dozmorov, PhD, Carlo Calissano, MD, Sonia Marsilio, PhD, Rajendra N Damle, PhD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Jacqueline C. Barrientos, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, MD

Blood (2012) 120 (21): 317.

https://doi.org/10.1182/blood.V120.21.317.317

Published: 2012

Journal Articles

Single Cell Network Profiling (SCNP) Identifies Altered Signaling Between Patient Risk Groups in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Jason Ptacek, PhD, Erik Evensen, Ph.D., Greg Friedland, James Cordeiro, Jodi R. Ware, PharmD, Charles C. Chu, PhD, Rajendra N Damle, PhD, Lu Zhang, MS, Nicholas Chiorazzi, MD, Alessandra Cesano, M.D., Ph.D., Rachael E. Hawtin, Ph.D.

Blood (2012) 120 (21): 2876.

https://doi.org/10.1182/blood.V120.21.2876.2876

Published: 2012

Journal Articles

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients

Rajendra N. Damle, Sonal Temburni, Taraneh Banapour, Santanu Paul, Patricia K. A. Mongini, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Nicholas Chiorazzi

Blood (2012) 120 (12): 2438–2449.

https://doi.org/10.1182/blood-2012-02-409110

Published: 2012

Journal Articles

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 1774.

https://doi.org/10.1182/blood.V118.21.1774.1774

Published: 2011

Journal Articles

Longitudinal Analyses of CXCR4 dim CD5 br CD19 + Fractions of Chronic Lymphocytic Leukemia Clones Reveal Features Consistent with a Source of Clonal Heterogeneity

Rajendra N Damle, PhD, Carlo Calissano, MD, Sonal Temburni, MS, Ryon M. Andersen, B.A., Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 804.

https://doi.org/10.1182/blood.V118.21.804.804

Published: 2011

Journal Articles

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

Xiao J. Yan, MD, PhD, Daniel Kalenscher, Erin Boyle, Sophia Yancopoulos, PhD, Rajendra N Damle, PhD, Aarti Damle, Houman Khalili, Annette Lee, PhD, Wentian Li, Ph.D., Igor Dozmorov, MD, PhD, Matthew Kaufman, M.D., Peter Gregersen, MD, Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 2833.

https://doi.org/10.1182/blood.V118.21.2833.2833

Published: 2011

Journal Articles

TLR-9 and B-Cell Antigen Receptor Triggering of Primary B Cells From Mantle Cell Lymphoma Induce Cell Proliferation and Telomerase Activity,

Sonal Temburni, MS, Ryon M. Andersen, B.A., Steven L. Allen, M.D., Jaqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D., Rajendra N Damle, PhD

Blood (2011) 118 (21): 3690.

https://doi.org/10.1182/blood.V118.21.3690.3690

Published: 2011

Journal Articles

B-Cell Chronic Lymphocytic Leukemia (B-CLL) Cells Unresponsive to CD180 Ligation Fail to Respond to Anti-IgM Stimulation as Well

Nino Porakishvili, PhD, Peter Lydyard, PhD, Anna Bremser, Ketki Vispute, Azka Memon, Nina Kulikova, Edward Clarke, Kanti R Rai, MD, Amit Nathwani, MD, PhD, Rajendra N Damle, PhD, Nicholas Chiorazzi

Blood (2010) 116 (21): 3582.

https://doi.org/10.1182/blood.V116.21.3582.3582

Published: 2010

Journal Articles

CCR4:CCL17 Interaction Influences TLR-9 Mediated Cell Survival and Proliferation In Chronic Lymphocytic Leukemia

Sonal C. Temburni, MS, Ryon M. Andersen, B.A., Luke Janson, B.A., Xiao-Jie Yan, MD;, Ph.D, Barbara Sherry, PhD, Matthew Kaufman, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD, Rajendra N. Damle, PhD

Blood (2010) 116 (21): 3593.

https://doi.org/10.1182/blood.V116.21.3593.3593

Published: 2010

Journal Articles

Chronic Lymphocytic Leukemia B Cells Variably Express Functional Activation-Induced Cytosine Deaminase Protein

Piers EM Patten, BSc, MBBCh, PhD, Charles C Chu, PhD, Rajendra N Damle, PhD, Steven L. Allen, MD, Jonathan E Kolitz, MD, Kanti R Rai, MD, Patricia K Mongini, PhD, Nicholas Chiorazzi, MD

Blood (2010) 116 (21): 378.

https://doi.org/10.1182/blood.V116.21.378.378

Published: 2010

Journal Articles

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Shih-Shih Chen, Ph.D., Matthew Kaufman, M.D., Angelica Caramanica, Rajendra N Damle, Ph.D., Peter Garofalo, Patricia Ly, Dale Janson, Steven L. Allen, M.D., Jonathan Kolitz, M.D., Linda Quill, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2010) 116 (21): 1392.

https://doi.org/10.1182/blood.V116.21.1392.1392

Published: 2010

Journal Articles

Elevated IL-17 Producing Cells (Th17 and Non-Th17) In Different CLL Microenvironments: Correlation with Overall Survival, Prognostic Relevance and Phenotypic Heterogenity

Preetesh Jain, MBBS, MD, DM, Mohammad Javadan, PhD, Franziska Feger, Pui Chiu, Stella Stefanova, Rajendra N Damle, PhD, Steven L. Allen, MD, Jonathan E Kolitz, MD, Kanti R Rai, MD, Nicholas Chiorazzi, Barbara Sherry

Blood (2010) 116 (21): 2442.

https://doi.org/10.1182/blood.V116.21.2442.2442

Published: 2010

Journal Articles

Differential Expression Genes of CLL Subgroups Defined by Ki67 Expression Level Which Correlated with Clinical Outcome

Xiao-Jie Yan, M.D., Ph.D., Daniel Kalenscher, Erin Boyle, Arrti Damle, Sophie Yancopoulos, Ph.D., Rajendra N Damle, PhD, Houman Khalili, Annette Lee, PhD, Wentian Li, Ph.D., Igor Dozmorov, MD, PhD, Matthew Kaufman, M.D., Peter Gregersen, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, M.D.

Blood (2010) 116 (21): 2435.

https://doi.org/10.1182/blood.V116.21.2435.2435

Published: 2010

Journal Articles

Detection of Activation-Induced Cytidine Deaminase RNA In CLL Cells Correlates with Shorter Patient Survival and High Numbers of CD38 + Cells

Charles C Chu, PhD, Piers EM Patten, BSc, MBBCh, PhD, Emilia Albesiano, PhD, Linda P Johnson, BS, William J Kennedy, RN, MS, Lu Zhang, MS, Amanda R Magli, BSE, Rajendra N Damle, PhD, Xiao-Jie Yan, MD, PhD, Shabirul Haque, PhD, Patricia K Mongini, PhD, Jonathan E Kolitz, MD, Steven L Allen, MD, Kanti R Rai, MD, Nicholas Chiorazzi, MD

Blood (2010) 116 (21): 2415.

https://doi.org/10.1182/blood.V116.21.2415.2415

Published: 2010

Journal Articles

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin

Charles C. Chu, Rosa Catera, Lu Zhang, Sebastien Didier, Briana M. Agagnina, Rajendra N. Damle, Matthew S. Kaufman, Jonathan E. Kolitz, Steven L. Allen, Kanti R. Rai, Nicholas Chiorazzi

Blood (2010) 115 (19): 3907–3915.

https://doi.org/10.1182/blood-2009-09-244251

Published: 2010

Includes: Supplemental data

NARROW

Fcgammariib Expression As a Prognostic Marker in Chronic Lymphocytic Leukemia

Ibrutinib Inhibits Concomitant TLR and BCR- Driven Proliferation of Chronic Lymphocytic Leukemia Cells and Overrides the Supportive Survival-Promoting Effects of Microenvironmental Signals

Reciprocal Densities of CXCR4 and CD5 Define Subfractions of Chronic Lymphocytic Leukemia Clones Differing in Phenotype and Response to Environmental Stimuli: Towards a Better Definition of Targetable Components of Leukemic Clones

Concomitant, T-Independent TLR9-Mediated and BCR-Mediated Activation Provides Signals For Optimal Telomerase Induction In Chronic Lymphocytic Leukemia Cells Regardless Of IGHV Mutation Status

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Single Cell Network Profiling (SCNP) Identifies Altered Signaling Between Patient Risk Groups in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Longitudinal Analyses of CXCR4 dim CD5 br CD19 + Fractions of Chronic Lymphocytic Leukemia Clones Reveal Features Consistent with a Source of Clonal Heterogeneity

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

TLR-9 and B-Cell Antigen Receptor Triggering of Primary B Cells From Mantle Cell Lymphoma Induce Cell Proliferation and Telomerase Activity,

B-Cell Chronic Lymphocytic Leukemia (B-CLL) Cells Unresponsive to CD180 Ligation Fail to Respond to Anti-IgM Stimulation as Well

CCR4:CCL17 Interaction Influences TLR-9 Mediated Cell Survival and Proliferation In Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia B Cells Variably Express Functional Activation-Induced Cytosine Deaminase Protein

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Elevated IL-17 Producing Cells (Th17 and Non-Th17) In Different CLL Microenvironments: Correlation with Overall Survival, Prognostic Relevance and Phenotypic Heterogenity

Differential Expression Genes of CLL Subgroups Defined by Ki67 Expression Level Which Correlated with Clinical Outcome

Detection of Activation-Induced Cytidine Deaminase RNA In CLL Cells Correlates with Shorter Patient Survival and High Numbers of CD38 + Cells

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only